ZIMV

ZimVie Inc. (ZIMV) | Rumor.io

ZimVie

ZIMV

Attention (50-day avg)0%

Attention rank (50-day avg)—

Bullish sentiment (50-day avg)—

Price to earnings ratio0

Market capitalization0

Earnings per share0

Dividend yield (TTM)—

Revenue (annual)0

Net income (annual)0

Social

What share of all stock conversation is about ZIMV?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% 0	0% 0	0% 0	0% 0

Jul 24

ZimVie Inc. (ZIMV) was spun off from Zimmer Biomet in 2022 to simplify the company's structure.
The spin-off did not affect ZimVie's operations, which continue to focus on its core business.
ZimVie's financial performance has been affected by lower guidance for 2025, leading investors to question the company's turnaround efforts.

Generated by AI

Sentiment

Of the messages about ZIMV that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	—	—	90.79% +16.68
Bearish	—	—	—	9.21% -16.68

Dec 18

ZimVie Inc. has successfully sold its spine business for $375M, allowing the company to pay down debt and focus on its higher-growth dental platform.
The deal is expected to be accretive to ZimVie's revenue growth rate, EBITDA margin, and cash flow conversion rate.
The sale of the spine business has led to a significant increase in ZimVie's stock price, with shares up over 40% and trading volume well above average.

Generated by AI

Topics

Of the messages about ZIMV that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Analysts	—	—	—	1.05%
Announcements	—	—	—	82.63%
Controversies	—	—	—	0%
Earnings	—	—	—	2.11%
Macro	—	—	—	0.53%
Technical Analysis	—	—	—	13.68%

Dec 18

ZimVie Inc. ($ZIMV) has entered into a definitive agreement to sell its spine business to H.I.G. Capital for $375 million.
The deal is expected to be accretive to ZimVie's revenue growth rate, EBITDA margin, and cash flow conversion rate by allowing the company to streamline operations and sharpen its focus as a well-positioned, pure-play dental company.
ZimVie's shares jumped more than 40% after the announcement, with the company's stock price surging to $13.00 from $11.22.

Generated by AI

Community

Of the messages about ZIMV, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	—	—	—	13.92%
Newcomers	—	—	—	86.08%

Regulars· Dec 18

The sale of ZimVie's spine business to H.I.G. Capital for $375 million is a significant transaction, with the buyer acquiring the business for $315 million plus a $60 million promissory note.
The regulars believe the sale price is a bargain, considering the valuation of $OFIX, another business in the same industry, which is currently valued at $500 million.
The stock price has surged 40% following the announcement, with some regulars expressing happiness at the sale and the potential for the remaining business to be valued at a similar amount to $OFIX.

Newcomers· Jul 22

The stock $ZIMV has surged 122% after announcing its acquisition by healthcare investment firm Archimed, with the deal offering a 99% premium to shareholders.
Analysts are upgrading their price targets for $ZIMV, with some predicting a significant increase in value, citing the stock's strong chart structure and volume.
The acquisition by Archimed has resulted in a significant increase in $ZIMV's market capitalization, with the stock's market cap now standing at $5.24B, and its float at around 217.7M shares.

Generated by AI

Also Discussed

Investors talking about ZIMV also mention

#	Name	Attention
1	SAB Biotherapeutics Inc.SABS	0%new
2	BSLK - Bolt Projects Holdings, Inc.	——
3	Telomir Pharmaceuticals, Inc.TELO	0%0
4	GlucoTrack Inc.GCTK	0%0
5	Above Food Ingredients Inc.ABVE	0%new
6	Dentsply Sirona Inc.XRAY	0%new
7	Solana Company Class A Common StockHSDT	0%0
8	BeOne Medicines Ltd. American Depositary SharesONC	0%0
9	Pineapple Financial Inc.PAPL	0%+0
10	Verrica Pharmaceuticals Inc.VRCA	0%0

ZimVie Inc.

Location

Social

What share of all stock conversation is about ZIMV?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% 0	0% 0	0% 0	0% 0

Jul 24

ZimVie Inc. (ZIMV) was spun off from Zimmer Biomet in 2022 to simplify the company's structure.
The spin-off did not affect ZimVie's operations, which continue to focus on its core business.
ZimVie's financial performance has been affected by lower guidance for 2025, leading investors to question the company's turnaround efforts.

Generated by AI

Sentiment

Of the messages about ZIMV that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	—	—	90.79% +16.68
Bearish	—	—	—	9.21% -16.68

Dec 18

ZimVie Inc. has successfully sold its spine business for $375M, allowing the company to pay down debt and focus on its higher-growth dental platform.
The deal is expected to be accretive to ZimVie's revenue growth rate, EBITDA margin, and cash flow conversion rate.
The sale of the spine business has led to a significant increase in ZimVie's stock price, with shares up over 40% and trading volume well above average.

Generated by AI

Topics

Of the messages about ZIMV that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Analysts	—	—	—	1.05%
Announcements	—	—	—	82.63%
Controversies	—	—	—	0%
Earnings	—	—	—	2.11%
Macro	—	—	—	0.53%
Technical Analysis	—	—	—	13.68%

Dec 18

ZimVie Inc. ($ZIMV) has entered into a definitive agreement to sell its spine business to H.I.G. Capital for $375 million.
The deal is expected to be accretive to ZimVie's revenue growth rate, EBITDA margin, and cash flow conversion rate by allowing the company to streamline operations and sharpen its focus as a well-positioned, pure-play dental company.
ZimVie's shares jumped more than 40% after the announcement, with the company's stock price surging to $13.00 from $11.22.

Generated by AI

Community

Of the messages about ZIMV, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	—	—	—	13.92%
Newcomers	—	—	—	86.08%

Regulars· Dec 18

The sale of ZimVie's spine business to H.I.G. Capital for $375 million is a significant transaction, with the buyer acquiring the business for $315 million plus a $60 million promissory note.
The regulars believe the sale price is a bargain, considering the valuation of $OFIX, another business in the same industry, which is currently valued at $500 million.
The stock price has surged 40% following the announcement, with some regulars expressing happiness at the sale and the potential for the remaining business to be valued at a similar amount to $OFIX.

Newcomers· Jul 22

The stock $ZIMV has surged 122% after announcing its acquisition by healthcare investment firm Archimed, with the deal offering a 99% premium to shareholders.
Analysts are upgrading their price targets for $ZIMV, with some predicting a significant increase in value, citing the stock's strong chart structure and volume.
The acquisition by Archimed has resulted in a significant increase in $ZIMV's market capitalization, with the stock's market cap now standing at $5.24B, and its float at around 217.7M shares.

Generated by AI

ZimVie

Social

Jul 24

Sentiment

Dec 18

Topics

Dec 18

Community

Regulars· Dec 18

Newcomers· Jul 22

Also Discussed

ZimVie Inc.

Company Information

Location

Also Discussed

Social

Jul 24

Sentiment

Dec 18

Topics

Dec 18

Community

Regulars· Dec 18

Newcomers· Jul 22